Results 11 to 20 of about 430,871 (256)

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact [PDF]

, 2013
Background Estimation of pre-immunisation prevalence of HPV and distribution of HPV types is fundamental to understanding the subsequent impact of HPV vaccination.
Robertson, Charles, Cubie, Heather, Cuschieri, Kate, Love, John, Potts, Alison, Kavanagh, Kimberley, Pollock, Kevin G.J., Donaghy, Martin, Sinka, Katy   +8 more
core   +4 more sources

No Vacillation on HPV Vaccination [PDF]

Cell, 2018
Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.
Sipp, Douglas, Frazer, Ian H., Rasko, John E. J.   +2 more
openaire   +5 more sources

HPV Vaccine Recommendations [PDF]

Pediatrics, 2012
This Policy Statement was retired June 2015. On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males.
Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis   +12 more
openaire   +2 more sources

Special Issue: HPV and HPV Vaccines [PDF]

Viruses, 2022
Our fundamental understanding of papillomaviruses and their interactions with their host, including their role in cancer and how the immune system responds to them, has made the elimination of cervical cancer a realistic global health goal [...]
openaire   +3 more sources

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland [PDF]

, 2014
In Scotland, a national HPV immunisation programme began in 2008 for 12-13 year olds, with a catch-up campaign from 2008-2011 for those under the age of 18.
Kavanagh, K, Cruickshank, M, Cubie, H., C Robertson, Pollock, Kevin G.J., J Love, Pollock, K G J, Potts, A., Love, J., K Kavanagh, Cruickshank, M., Nicoll, Sheila, Donaghy, Martin, Palmer, Tim J, K Cuschieri, Robertson, C, Palmer, T J, M Donaghy, Cuschieri, K., Robertson, C., H, Cubie,, Potts, Alison, H Cubie, M Cruickshank, Nicoll, S., Donaghy, M, Pollock, K. G. J., Potts, A, Love, John, Cuschieri, Kate, Kavanagh, K., Donaghy, M., S Nicoll, Cuschieri, K, Cubie, H, Nicoll, S, Cruickshank, Maggie, T J Palmer, Love, J, Kavanagh, Kimberley, K G J Pollock, Robertson, Chris, Palmer, T. J., A Potts   +43 more
core   +1 more source

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. [PDF]

PLoS Medicine, 2010
BACKGROUND: Information on factors that influence parental decisions for actual human papillomavirus (HPV) vaccine receipt in publicly funded, school-based HPV vaccine programs for girls is limited.
Gina Ogilvie, Maureen Anderson, Fawziah Marra, Shelly McNeil, Karen Pielak, Meena Dawar, Marilyn McIvor, Thomas Ehlen, Simon Dobson, Deborah Money, David M Patrick, Monika Naus   +11 more
doaj   +1 more source

Review of the current published evidence for single-dose HPV vaccination 4th Ediion [PDF]

, 2022
The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine.
Single-Dose HPV Vaccine Evaluation Consortium
core   +4 more sources

Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study

Papillomavirus Research, 2017
Background: Most college males are not immunized against the human papillomavirus (HPV) and are at high risk of HPV infection. Most research of correlates of HPV vaccine acceptability in college males has assessed vaccine acceptability as a binary ...
Ovidiu Tatar, Samara Perez, Anila Naz, Gilla K. Shapiro, Zeev Rosberger   +4 more
doaj   +1 more source

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Papillomavirus Research, 2016
Background: Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. Methods: We conducted a retrospective cohort study using the 2008–2011 MarketScan data to examine HPV vaccine ...
Guodong Liu, Lan Kong, Ping Du
doaj   +1 more source

Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. [PDF]

, 2012
BACKGROUND: There are few data on factors influencing human papillomavirus (HPV) vaccination uptake in sub-Saharan Africa. We examined the characteristics of receivers and non-receivers of HPV vaccination in Tanzania and identified reasons for not ...
Soteli, Selephina, Kathy Baisley, Tomlin, Keith, de Sanjosé, Silvia, Kapiga, Saidi, Changalucha, John, Pieter Remes, Selephina Soteli, Hayes, Richard J., Riziki Ponsiano, Watson-Jones, Deborah, John Changalucha, Sanjosé Llongueras, Silvia de, Remes, Pieter, Saidi Kapiga, Richard J Hayes, Hayes, Richard J, Deborah Watson-Jones, Keith Tomlin, Silvia de Sanjosé, Baisley, Kathy, Ponsiano, Riziki   +21 more
core   +1 more source